Near-elimination of the hepatitis C virus in a prison population in North Queensland has occurred in less than two years since direct-acting antiviral (DAA) therapy became available on the PBS. And it has been achieved without a controversial needle and syringe program (NSP). According to a report in Clinical Infectious Diseases, HCV prevalence in Lotus ...

Already a member?
Enter your email to keep reading.
OR